[Congenital hypopituitarism: report of 23 cases].

Rev Med Chil

Instituto de Investigaciones Materno Infantil, Facultad de Medicina, Universidad de Chile, Santiago, Chile.

Published: August 2008

Background: Congenital hypopituitarism is an uncommon cause of hypophyseal insufficiency It is less common than growth hormone deficiency which has an incidence of 1:4.000 to 1:8.000 live newborns. Early diagnosis of this condition is important to prevent impairment of cognitive function, poor growth and alterations in metabolic profile in these patients.

Aim: To report 23 patients diagnosed with congenital hypopituitarism.

Material And Methods: Retrospective review of clinical records of 23 patients (12 males) with congenital hypopituitarism, diagnosed during a 21 years period. In a group of 16 patients a molecular study was performed searching for mutations in HESX1, PROP-1 or POUF-1.

Results: Short stature was the most frequent sign at the first evaluation, followed by neonatal hypoglycemia and presence of nystagmus, strabismus, atrophic optic nerve or malformations in the middle line showed in CNS imaging, suggesting septo-optic-dysplasia. All male patients diagnosed during neonatal period, exhibited micropenis. CNS images showed isolated hypophyseal hypoplasia or associated to an ectopic neurohypophysis in most patients. No patient in the subgroup subjected to molecular analysis had any of the mutations in the searched genes.

Conclusions: The diagnosis of hypopituitarism must be based on clinical grounds, especially when hypoglycemia, prolonged jaundice, micropenis or midline alterations are found in the neonatal period.

Download full-text PDF

Source

Publication Analysis

Top Keywords

congenital hypopituitarism
8
patients diagnosed
8
neonatal period
8
patients
5
[congenital hypopituitarism
4
hypopituitarism report
4
report cases]
4
cases] background
4
background congenital
4
hypopituitarism uncommon
4

Similar Publications

Objectives: In the last two decades, scientists have gained a better understanding of several aspects of pituitary development. The signaling pathways that govern pituitary morphology and development have been identified, and the compensatory relationships among them are now known.

Aims: This paper aims to emphasize the wide variety of relationships between Pituitary Gland and Stem cells in hormone Production and disease prevention.

View Article and Find Full Text PDF

Purpose: To investigate the clinical characteristics and genetic features of childhood-onset congenital combined pituitary hormone deficiency (cCPHD) in Korean patients.

Methods: We retrospectively analyzed 444 patients diagnosed with childhood-onset CPHD at a tertiary center between 1994 and 2021. After excluding acquired case, 43 patients with cCPHD were enrolled.

View Article and Find Full Text PDF

An Update on Advances in Hypopituitarism: Etiology, Diagnosis, and Current Management.

J Clin Med

October 2024

Department of Endocrinology and Nutrition, Hospital Universitario Puerta de Hierro Majadahonda, Calle Joaquín Rodrigo, 1, 28222 Majadahonda, Madrid, Spain.

Article Synopsis
  • - This article reviews hypopituitarism (HP), a condition where the pituitary gland doesn't produce enough hormones, detailing its causes like tumors, genetic issues, and other factors such as trauma and medications.
  • - Diagnosis involves clinical evaluations and hormonal tests, although these tests can have limitations; identifying specific hormonal deficiencies is critical for treatment.
  • - Hormone replacement therapy is the main treatment for HP, improving patient quality of life, but awareness of potential interactions among therapies is crucial; ongoing research and a multidisciplinary approach are also highlighted for better management of the disorder.
View Article and Find Full Text PDF

Introduction: Congenital hypopituitarism (CH) is characterized by the deficiency of pituitary hormones. Among CH patients, 85% lack a molecular diagnosis. Whole Exome Sequencing (WES) identified a homozygous variant (c.

View Article and Find Full Text PDF

Introduction: Hypogonadotropic hypogonadism (HH) is a treatable cause of nonobstructive azoospermic male infertility. Gonadotropin treatment can successfully induce spermatogenesis in most patients, although comprehensive quantitative summary data on spermatogenic outcomes like those required to induce pregnancy is lacking in the literature.

Materials And Methods: Systematic review and meta-analysis of outcomes related to male reproductive function following gonadotropin treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!